tradingkey.logo

Apimeds Pharmaceuticals US Inc

APUS
View Detailed Chart

1.740USD

+0.005+0.29%
Close 08/01, 16:00ETQuotes delayed by 15 min
13.75MMarket Cap
LossP/E TTM

Apimeds Pharmaceuticals US Inc

1.740

+0.005+0.29%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.29%

5 Days

-21.62%

1 Month

-2.25%

6 Months

0.00%

Year to Date

0.00%

1 Year

0.00%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(5)
Neutral(3)
Buy(0)
Indicators
Sell(1)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.053
Neutral
RSI(14)
43.199
Neutral
STOCH(KDJ)(9,3,3)
8.703
Oversold
ATR(14)
0.270
High Vlolatility
CCI(14)
-94.581
Neutral
Williams %R
92.484
Oversold
TRIX(12,20)
0.433
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(4)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
--
--
MA10
--
--
MA20
--
--
MA50
--
--
MA100
--
--
MA200
--
--

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Ticker SymbolAPUS
CompanyApimeds Pharmaceuticals US Inc
CEOMr. Erik C. Emerson
Websitehttps://www.apimedsus.com/
KeyAI